WHO experts take another look at aspartame’s safety
Jun 30, 2023
Aspartame continues to have approval from the US Food and Drug Administration as a safe product.
Intranasal insulin may have pro-cognitive benefits
Jun 30, 2023
Improvement in global cognition was seen for patients with Alzheimer’s disease/mild cognitive impairment, but no effects were seen for healthy individuals or other patient populations.
Low-carb breakfast aids glucose measures with diabetes
Jun 22, 2023
The analysis included 121 participants randomly assigned to a low-carb or low-fat breakfast for three months.
Intensive inpatient BP management not beneficial in seniors
Jun 21, 2023
The risk for adverse events increased with intensive treatment among older adults with elevated BP in the first 48 hours of hospitalization.
In-hospital wearable activity trackers tied to improved outcomes
Jun 16, 2023
Patients using wearable trackers had higher physical activity and functioning.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
Oseltamivir not linked to reduced risk for flu hospitalization
Jun 14, 2023
No reduced risk was seen among older patients or those at risk for hospitalization.
AI-based coach promising for behavioral therapy
Jun 12, 2023
The benefits were seen in neuroimaging and problem-solving, as well as depression and anxiety symptoms.
Risk for stroke increased in association with insomnia symptoms
Jun 09, 2023
The association was stronger in participants younger than 50 years; mediators included diabetes, hypertension, heart disease and depression.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.